First Trust Advisors LP Bio N Tech Se Transaction History

First Trust Advisors LP

$101 Billion
Q3 2024

A detailed history of First Trust Advisors LP transactions in Bio N Tech Se stock. As of the latest transaction made, First Trust Advisors LP holds 451,192 shares of BNTX stock, worth $51.5 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

451,192

Previous 409,053 10.3%

Holding current value

$51.5 Million

Previous $32.9 Million 63.03%

% of portfolio

0.05%

Previous 0.03%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$78.36 - $124.66 $3.3 Million - $5.25 Million	42,139 Added 10.3%	451,192 $53.6 Million
Q2 2024 Aug 13, 2024	BUY	$80.36 - $102.87 $32.9 Million - $42.1 Million	409,053 New	409,053 $32.9 Million
Q4 2023 Feb 13, 2024	SELL	$90.91 - $112.75 $219,911 - $272,742	-2,419 Reduced 0.58%	416,891 $44 Million
Q3 2023 Nov 13, 2023	BUY	$98.5 - $125.08 $1.07 Million - $1.36 Million	10,895 Added 2.67%	419,310 $45.6 Million
Q2 2023 Aug 14, 2023	BUY	$102.58 - $129.66 $4.9 Million - $6.19 Million	47,760 Added 13.24%	408,415 $44.1 Million
Q1 2023 May 15, 2023	BUY	$122.57 - $153.67 $1.03 Million - $1.29 Million	8,393 Added 2.38%	360,655 $44.9 Million
Q4 2022 Feb 09, 2023	BUY	$118.43 - $186.05 $9.07 Million - $14.2 Million	76,552 Added 27.77%	352,262 $52.9 Million
Q3 2022 Nov 14, 2022	SELL	$127.65 - $183.11 $5.21 Million - $7.48 Million	-40,834 Reduced 12.9%	275,710 $37.2 Million
Q2 2022 Aug 12, 2022	SELL	$123.25 - $186.24 $21.4 Million - $32.3 Million	-173,407 Reduced 35.39%	316,544 $47.2 Million
Q1 2022 May 13, 2022	BUY	$126.25 - $231.85 $23.7 Million - $43.5 Million	187,569 Added 62.03%	489,951 $83.6 Million
Q4 2021 Feb 08, 2022	SELL	$216.64 - $362.52 $14.6 Million - $24.4 Million	-67,227 Reduced 18.19%	302,382 $78 Million
Q3 2021 Nov 15, 2021	BUY	$205.93 - $447.23 $55.3 Million - $120 Million	268,440 Added 265.34%	369,609 $101 Million
Q2 2021 Aug 16, 2021	SELL	$113.32 - $241.49 $4.75 Million - $10.1 Million	-41,889 Reduced 29.28%	101,169 $22.7 Million
Q1 2021 May 14, 2021	BUY	$85.73 - $119.5 $12.3 Million - $17.1 Million	143,058 New	143,058 $15.6 Million

Others Institutions Holding BNTX

# of Institutions

357

Shares Held

38.3M

Call Options Held

2.45M

Put Options Held

2.29M

View Full List

About BioNTech SE

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $27.7B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

More about BNTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.

Account

First Trust Advisors LP Bio N Tech Se Transaction History